Showing results (91-100 of 129) with videos related to
Sort By:
Pageof 13
Plos One|October 22, 2020
Comprehensive analysis of mitochondrial and nuclear DNA variations in patients affected by hemoglobinopathies: A pilot studyYlenia Barbanera, Francesco Arcioni, Hovirag Lancioni, et al.European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|February 1, 2011
Clinical management of cardiovascular complications in patients with thalassaemia major: a large observational multicenter studyGiorgio Derchi, Francesco Formisano, Manuela Balocco, et al.Internal and Emergency Medicine|June 28, 2018
Risk factors for heart disease in transfusion-dependent thalassemia: serum ferritin revisitedGiorgio Derchi, Carlo Dessì, Patrizio Bina, et al.Circulation|October 2, 2013
Prevalence and risk factors for pulmonary arterial hypertension in a large group of β-thalassemia patients using right heart catheterization: a Webthal studyGiorgio Derchi, Renzo Galanello, Patrizio Bina, et al.British Journal of Haematology|December 17, 2003
Hepatocellular carcinoma in the thalassaemia syndromesCaterina Borgna-Pignatti, Gianluca Vergine, Turi Lombardo, et al.British Journal of Haematology|July 9, 2002
The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patientsAdriana Ceci, Paola Baiardi, Mariagrazia Felisi, et al.Hemoglobin|April 1, 2017
The Molecular Spectrum of β- and α-Thalassemia Mutations in Non-Endemic Umbria, Central ItalyPaolo Gorello, Francesco Arcioni, Antonietta Palmieri, et al.Blood|December 15, 2005
Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosisDudley J Pennell, Vasili Berdoukas, Markissia Karagiorga, et al.American Journal of Hematology|October 28, 2014
Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamineDudley J Pennell, John B Porter, Antonio Piga, et al.Journal of Clinical Pharmacology|February 19, 2008
Effect of food, type of food, and time of food intake on deferasirox bioavailability: recommendations for an optimal deferasirox administration regimenRenzo Galanello, Antonio Piga, Maria Domenica Cappellini, et al.Pageof 13